Objective: We sought to determine the liver X receptor (LXR) ligands present in human macrophages after myelin phagocytosis and whether LXRs are activated in multiple sclerosis (MS) lesions. Methods: We used real-time quantitative polymerase chain reaction (PCR) and immunohistochemistry to determine expression of LXRs and their response genes in human phagocytes after myelin phagocytosis and in active MS lesions. We used gas chromatographic/mass spectrometric analysis to determine LXRactivating oxysterols and cholesterol precursors present and formed in myelin and myelin-incubated cells, respectively. Results: Myelin induced LXR response genes ABCA1 and ABCG1 in human monocyte-derived macrophages. In active MS lesions, we found that both gene expression and protein levels of ABCA1 and apolipoprotein E (APOE) are upregulated in foamy phagocytes. Moreover, we found that the LXR ligand 27-hydroxycholesterol (27OHC) is significantly increased in human monocyte-derived macrophages after myelin uptake. Conclusion: LXR response genes are upregulated in phagocytes present in active MS lesions, indicating that LXRs are activated in actively demyelinating phagocytes. In addition, we have shown that myelin contains LXR ligands and that 27OHC is generated in human monocyte-derived macrophages after myelin processing. This suggests that LXRs in phagocytes in active MS lesions are activated at least partially by (oxy)sterols present in myelin and the generation thereof during myelin processing.
Introduction
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS). 1 Acute inflammatory focal demyelination and the resulting neurodegeneration are among the most prominent pathological hallmarks of MS. Monocyte-derived macrophages and resident microglia secrete inflammatory and toxic mediators that negatively impact axonal and myelin integrity. [2] [3] [4] Moreover, phagocytes contribute to MS lesion formation by phagocytosing myelin, apoptotic cells, and cellular debris. Although degeneration of myelin is considered detrimental, its clearance is essential prior to initiation of remyelination. Myelin debris contains proteins that inhibit both axonal regrowth and differentiation of oligodendrocyte precursor cells into mature oligodendrocytes during remyelination. 5, 6 This emphasizes the cardinal role of phagocytes in stimulating CNS repair.
Cholesterol is the most abundant lipid within myelin 7 and plays a key role in myelination, illustrated by perturbed myelin formation in mice with defective cholesterol synthesis in the myelin-forming oligodendrocytes. 8 Virtually all cholesterol within the CNS is synthesized in situ, and a stable turnover is necessary to maintain cholesterol homeostasis. 9 Breakdown of myelin results in a disturbed CNS cholesterol metabolism in MS patients, demonstrated by altered plasma levels of CNS-specific cholesterol metabolites 24(S)-hydroxycholesterol (24SOHC) and 27-hydroxycholesterol (27OHC). [10] [11] [12] Infiltrating macrophages and resident microglia phagocytose myelin resulting to an increased uptake of cholesterol. This may lead to the formation of intracellular oxysterols. Oxysterols and other intermediates of the cholesterol biosynthetic pathway, such as desmosterol, are natural liver X receptor (LXR) ligands, fueling cellular sterol efflux. 13 Both isoforms, LXRα and LXRβ, are expressed in the CNS and immune cells. 14, 15 When activated, LXRs heterodimerize with retinoid X receptors (RXRs). They regulate the expression of genes that participate in reverse cholesterol transport, such as adenosine triphosphate (ATP)-binding cassette transporter (ABC) A1, ABCG1, and apolipoprotein E (APOE). LXRs have also emerged as suppressors of inflammatory pathways in macrophages through SUMOylation. 16, 17 Evidence is emerging that macrophages display an anti-inflammatory phenotype upon myelin phagocytosis, [18] [19] [20] suggesting that myelin contains functional LXR ligands or leads to the formation thereof. Recently, we demonstrated that myelin-derived lipids are able to activate LXRs in rat macrophages and skew these macrophages toward a less inflammatory phenotype in vitro. 21 However, it is currently unknown if LXRs are activated in phagocytes in active MS lesions. We hypothesize that the uptake of myelin and the subsequent formation of LXR ligands result in the activation of LXRs in phagocytes in active MS lesions.
We show that phagocytosis of myelin by human monocyte-derived macrophages leads to a significant induction of LXR response genes. In addition, we show that infiltrated macrophages and resident microglia express enhanced levels of LXRα, ABCA1, and APOE in active demyelinating lesions. Finally, we show that the oxysterol 27OHC is formed after myelin uptake and processing. The formation of this LXR ligand may explain the LXR activation seen in myelin-phagocytosing phagocytes in active demyelinating lesions.
Methods

Myelin isolation
Myelin was purified from human brain tissue by density-gradient centrifugation, as described previously. 22 Protein concentration was determined using a bicinchoninic acid (BCA) protein assay kit (Thermo Fisher Scientific, Erembodegem, Belgium). Endotoxin content was determined using a LAL Chromogenic Endotoxin Quantitation Kit (Thermo Fisher). The isolated myelin contained a negligible amount of endotoxin (<1.8 × 10 −3 pg/µg myelin).
Cell culture
Human peripheral blood mononuclear cells (PBMCs) were obtained from consented healthy donors using Ficoll (Cedarlane Labs, Canada) density gradient. Monocytes were isolated from the PBMCs by anti-CD14 EasySep microbeads (Stemcell Technologies, Grenoble, France) according to manufacturer's instructions. Monocytes (1 × 10 6 cells/mL) were cultured in 24-well plates (Greiner Bio-One, Belgium) in macrophage differentiation medium (Roswell Park Memorial Institute (RPMI); Lonza, Vervier, Belgium), supplemented with 10% v/v normal fetal calf serum (Life Technologies, Ghent, Belgium) and 50 U/mL v/v penicillin-streptomycin (Sigma-Aldrich, Bornem, Belgium)), at 37°C, 5% CO 2 . Monocytes matured into macrophages in the course of 7 days. For experiments, myelin (100 µg/mL) was added to macrophages for 24 hours preceding messenger RNA (mRNA) extraction.
Autopsy material
Brain tissue samples were obtained from the Netherlands Brain Bank. All patients, healthy controls or their next of kin, had given informed consent for autopsy and use of brain tissue for research purposes. Active lesions were immunohistochemically characterized as lesions with abundant immune cell infiltrates and extensive myelin loss (Table 1) .
Quantitative polymerase chain reaction
Total RNA was prepared using the RNeasy Mini Kit (Qiagen, Venlo, The Netherlands) according to the manufacturer's instructions with the following modification: Qiazol lysis reagent (Qiagen) with 1% β-mercaptoethanol (Sigma-Aldrich) was used as lysis buffer. RNA concentration and purity was determined using a Nanodrop spectrophotometer (Isogen Life Science, Ijsselstein, The Netherlands). RNA was converted to complementary DNA (cDNA) using qScript cDNA SuperMix (Quanta Biosciences, Boston, MA) according to the manufacturer's instructions. Quantitative polymerase chain reaction (qPCR) was conducted on a StepOnePlus ™ real-time PCR system (Applied Biosystems, Ghent, Belgium). The SYBR green master mix (Applied Biosystems), 10 µM of forward and reverse primers, nuclease-free water, and 12.5 ng template cDNA in a total reaction volume of 10 µL. Relative quantification of gene expression was accomplished using the comparative C t method. Data were normalized to the most stable reference genes. Primers were chosen according to the literature or designed using Primer Express (http:// www.ncbi.nlm.nih.gov/tools/primer-blast). Details of primers used are shown in Table 2 .
Immunohistochemistry Snap-frozen brain tissue was sectioned at 5 µm and stained for proteolipid protein (PLP, 1:500, MCA839G; AbD Serotec, Temse, Belgium) and human leukocyte antigen-antigen D related (HLA-DR; biotin-labeled clone LN3; eBioscience, Vienna, Austria; 13-9956) to determine MS lesion type. All antibodies were diluted in phosphate-buffered saline (PBS) with 1% bovine serum albumin (BSA; Sigma-Aldrich).
For 3,3′-diaminobenzidine (DAB) stainings, sections were air-dried and fixed in acetone for 10 minutes. Endogenous peroxidase activity was quenched by incubating the slides in 0.3% hydrogen peroxide. 
Oil Red O staining
Myelin-treated human monocyte-derived macrophages were fixed using 4% paraformaldehyde (Sigma-Aldrich) for 20 minutes. Next, the cells were stained with Oil Red O (ORO; Sigma-Aldrich) for 10 minutes and exhaustively rinsed with water. In order to quantify intracellular myelin levels, 1 mL of isopropyl alcohol was added to the stained culture dish, and the extracted dye was immediately removed by gentle pipetting, and its absorbance was determined spectrophotometrically at 510 nm. To delineate active MS lesion tissue for qPCR, cryosections (unfixed) were stained with ORO for 10 minutes and exhaustively rinsed with water. Next, a hematoxylin counterstain was applied, and cryosections were subsequently mounted.
Sterol analysis
Human monocyte-derived macrophages were treated with or without 100 µg/mL human myelin for 24 hours. Next, the medium containing myelin was collected and stored for further analysis, while cells were incubated for another 4 days in fresh medium. Cells were then lysed in 1M NaOH (in 80% ethanol), and sterols were subsequently extracted from cell lysates and medium using chloroform-methanol (2:1). Sterol levels were determined by gas chromatograph/mass spectrometer (GC/MS) as described previously. 23, 24 The change in amount of sterols was determined by subtracting (condition with myelin) from (condition no myelin) and subsequently dividing it by the amount of sterols present in pure myelin after normalizing with the plant sterol campesterol, which is not metabolized by mammalian cells. 25 A flow diagram of the experimental design is included in Figure 4 (b). The Mann-Whitney U analysis (MWU, n1, n2; p) was used for datasets which did not pass normality. *p < 0.05, **p < 0.01, and ***p < 0.001.
Statistical analysis
Results
Induction of LXR response gene expression in human monocyte-derived macrophages after myelin uptake
To investigate whether LXRs in human monocytederived macrophages are activated after myelin uptake, we determined the expression of well-known LXR downstream targets by real-time qPCR analysis. mRNA expression of the autoregulated LXRα and LXR response genes ABCA1 and ABCG1 was increased in myelin-treated cells, compared to nontreated cells, whereas LXRβ and APOE mRNA levels remained unchanged (Figure 1 ). The C t value of LXRα in unstimulated cells is lower than LXRβ (LXRα: 17.91 vs LXRβ: 26.38). The threshold cycle is inversely proportional to the expression level indicating that LXRα mRNA expression is ~250 times higher than LXRβ in human macrophages ( Figure S1 ).
This indicates that LXRα appears to be the dominant driver behind LXR signaling in macrophages.
Induction of LXR response gene expression in active MS lesions
To determine whether LXRs are activated in MS lesions, gene expression levels of LXRs and downstream targets were determined ( Figure 2 ). RNA was isolated from regions accommodating lipid-containing macrophages and microglia, determined by ORO staining. mRNA expression of LXRα and its response genes ABCA1 and APOE were increased in active lesions, compared to white matter tissue from nonneurological controls (Figure 2(a) , (c) and (e)). Moreover, LXRβ mRNA expression was significantly reduced in active MS lesions, whereas the expression of ABCG1 remained unchanged. These results show LXR response genes are upregulated in active demyelinating MS lesions.
LXR downstream targets ABCA1 and APOE are upregulated in phagocytes in active MS lesions
To determine whether LXR response genes are also induced at protein level in MS lesions and to establish the cellular location of this induction, we determined the expression of LXRs and LXR response genes in active MS lesions by immunohistochemistry. For this purpose, we selected active demyelinating MS lesions of four MS cases ( Table 1) . Identification of active lesions was based on immunohistochemical analysis of phagocytes (anti-HLA-DR) and PLP. Active lesions are characterized by extensive myelin loss and abundant myelin-containing phagocytic macrophages and microglia (Figure 3(a)-(c) ). We found that the LXR response genes ABCA1, APOE, LXRα, and LXRβ are abundantly expressed in active lesions (Figure 3(d) , (e), (g), (h), (j), (k), (m), and (n)). Double immunofluorescence stainings revealed that ABCA1, APOE, and LXRα/β were highly expressed in HLA-DR + cells with a foamy appearance (Figure 3(f) , (i), (l), and (o)), suggesting that LXRs are activated in phagocytes in active MS lesions.
27OHC is formed in human monocyte-derived macrophages after myelin ingestion
After myelin is phagocytosed, it is degraded inside the cell (Figure 4(a) ). Myelin, visualized by ORO staining, is rapidly phagocytosed, and intracellular levels remain stable until day 4. At day 5, a decline can be seen, indicating processing of myelin and possibly the release of cholesterol oxidation products. Using GC/MS, we determined cellular oxysterol levels in human macrophages, treated with or without myelin incubated for 5 days. We compared these levels with the levels present in human myelin (Figure 4 (b) and (c)). We found that while levels of cholesterol and the LXR ligand desmosterol were decreased after 5 days of myelin ingestion, 27OHC, but not 24OHC levels, were significantly increased in macrophages.
27OHC induces LXR response gene expression in human monocyte-derived macrophages
We calculated that the concentration of 27OHC present per 1 × 10 6 macrophages after 5 days of myelin incubation is around 5 µM. Therefore, we treated human monocyte-derived macrophages with 27OHC to determine whether the level of 27OHC induced in myelin-phagocytosing macrophages is sufficient to induce LXR response gene expression ( Figure 5 ). The expression of LXRα (MWU = 0; 5; 5; p < 0.008) and its response genes ABCA1 (MWU = 1; 5; 5; p < 0.016) and ABCG1 (MWU = 0; 5; 5; p < 0.008) was significantly increased in 27OHC-treated cells, compared to nontreated cells, whereas LXRβ and APOE mRNA expression remained unchanged. These results suggest that the amount of 27OHC present in vitro after myelin phagocytosis activates LXRs.
Discussion
In this study, we show that LXRs and their downstream targets are induced in myelin-laden macrophages in active demyelinating MS lesions, indicative of LXR activation. In active lesions, macrophages and activated microglia contribute to lesion progression by phagocytosing large quantities of myelin. Conceivably, upon myelin processing, LXR ligands are released leading to the upregulation and activation of LXRs and their response genes. LXRs are master regulators of cholesterol metabolism and inflammatory responses and are critical for brain homeostasis. By activation of LXRs, reverse cholesterol transport is induced which protects myelinphagocytosing cells from elevated intracellular free cholesterol and oxysterol-induced toxicity. 26 In the brain, LXRβ is ubiquitously expressed, whereas LXRα expression is largely restricted to infiltrating macrophages and microglia. 14,15 Table 1 , no.: 1-6) and active MS lesions (n = 5, see Table 1 , no.: 7-11). Relative quantification of (a) LXRα (MWU = 6; 6; 5; p < 0.012), (b) LXRβ (t(11) = 3.620; p < 0.004), (c) ABCA1 (t(12) = 4.293; p < 0.001), (d) ABCG1, and (e) APOE (MWU = 9; 6; 5; p < 0.036) was accomplished using comparative C t method. Data were normalized to the most stable reference genes, determined by Genorm (YWHAZ and Rpl13a).
NDC: nondemented controls.
We found LXRα expression in active lesions to be mainly present in HLA-DR + cells. Similarly, LXRβ expression was observed in HLA-DR + cells and perilesional astrocytes (data not shown). Although both isoforms are expressed by phagocytes, it appears that LXRα, at least at mRNA level, is the dominant driver behind LXR signaling in macrophages, 27 which is also evidenced by our in vitro data ( Figure 1 ). However, it is likely that due to translational and/or posttranslational regulation, the protein expression ratio differs from the gene expression ratio. In line herewith, we show that the difference in the expression level of LXRα and LXRβ is less clear on protein level in acute MS lesions (Figure 3 ). Microarray analysis of myelin-laden rat macrophages showed that the expression of LXR response gene ABCA1 was significantly upregulated compared to nontreated cells. 21 In concordance, we found that ABCA1 is induced in both myelin-treated human monocytederived macrophages and active MS lesions. In summary, based on the observation that downstream targets of LXRs are highly upregulated in myelinladen phagocytes, it is likely that LXRs are activated upon myelin digestion in active MS lesions.
Myelin contains various lipids and oxysterols that can influence macrophage function. Recently, we demonstrated that myelin phagocytosis alters macrophage phenotype in rat macrophages through activation of LXRs. 21 Therefore, we hypothesized that the uptake of myelin and the subsequent formation of LXR ligands results in the activation of LXRs in phagocytes in active MS lesions. We measured (oxy)sterols present in myelin such as desmosterol, 24SOHC, and 27OHC that are known to potently activate LXRs. [28] [29] [30] [31] After myelin phagocytosis, myelin is processed by the phagocyte, possibly generating cholesterol oxidation products, such as oxysterols. We found that 5 days after uptake of myelin by macrophages, intracellular myelin levels start to decrease, and the levels of the cholesterol metabolite 27OHC, but not 24SOHC and desmosterol, are significantly elevated. Taken together, these results indicate that LXR ligands are present in human myelin and that after myelin processing, 27OHC is one of the major LXR ligands that is formed.
The amount of 27OHC present in vitro in macrophages after myelin phagocytosis activates both LXR-isoforms with a higher affinity for LXRα. 29, 32 Exposing macrophages to 27OHC resulted, very similarly to myelin, in upregulation of LXRα, and LXR response genes ABCA1 and ABCG1. Based on these data, we speculate that initially LXRs are activated by Human monocyte-derived macrophages were treated with 100 µg/ mL myelin for 24 hours; after which, the unbound myelin was washed away and cells incubated for another 4 days. Next, cholesterol, desmosterol, and oxysterol levels were determined in the samples using GC/MS. Sterols were normalized using the plant sterol campesterol which is not metabolized. Relative levels of cholesterol (t(4) = 5.318; p < 0.006, •), desmosterol (t(4) = 6.503; p < 0.003, ■), 24OH (▲), and 27OH (t(4) = 3.720; p < 0.021, ▼) are shown (n = 5).
ligands present in myelin (e.g. 24SOHC, 27OHC, and desmosterol), while during later stages also, LXR ligands that are generated after myelin processing contribute to LXR activation.
Collectively, based on the observation that downstream targets of LXRs are upregulated in myelinladen phagocytes in active MS lesions, it is conceivable that LXRs are activated by ligands present in myelin. Moreover, 27OHC is the major LXR ligand that is formed after myelin processing, and the levels of 27OHC that are generated are capable of upregulating LXR downstream targets in phagocytes indicating that 27OHC is, at least in part, responsible for activation of LXRs in MS lesions. Although myelin is very stable in content, it cannot be excluded that differences in myelin composition between and within individuals (e.g. different anatomical CNS regions) may modulate the conversion of cholesterol to 27OHC. LXRs are of great importance in regulating cholesterol homeostasis and protect cells from elevated intracellular free cholesterol and oxysterolinduced toxicity. 26 More importantly, LXRs have been shown to inhibit inflammatory gene expression and stimulate remyelination 16, 17, 33, 34 underscoring their significance as important regulators in MS pathogenesis. This notion is highlighted in a recent study in which a mutation was found in the LXRα gene in familial MS. 35 The clinical disease progression and severity for mutant LXRα carriers is evidenced by its rapid progression and severity. In this study, the authors suggest that the p.Arg415Gln mutation, located in the ligand-binding domain, prevents LXR activation by abrogating heterodimerization between LXR and RXR, resulting in loss of function. Because of the oxysterols present in myelin and the formation of cholesterol oxidation products, it is likely that myelin-laden phagocytes in MS are at least in part modulated by a myelin-mediated activation of LXRs, providing an intriguing hypothesis for the LXR-controlled self-limiting nature of MS lesion development.
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